C
Conduit Pharmaceuticals Inc
NASDAQ:CDT
Conduit Pharmaceuticals Inc
NASDAQ:CDT
Price:
5.12
USD
21.33%
Market Closed
Market Cap:
$22.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Conduit Pharmaceuticals Inc
NASDAQ:CDT
|
US |
|
D
|
Dida Inc
HKEX:2559
|
CN |
|
G
|
Guangdong Xinbao Electrical Appliances Holdings Co Ltd
SZSE:002705
|
CN |
|
Unisync Corp
TSX:UNI
|
CA |
|
BHG Group AB
STO:BHG
|
SE |
|
Dorel Industries Inc
F:DO4C
|
CA |
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
KR |
|
W-Scope Corp
TSE:6619
|
JP |
|
BiVictriX Therapeutics PLC
LSE:BVX
|
UK |
|
Securitas AB
STO:SECU B
|
SE |
|
W
|
Western Union Co
XETRA:W3U
|
US |
Income Statement
Earnings Waterfall
Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals Inc
Income Statement
Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals Inc
Currency: USD
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(3)
|
(4)
|
(6)
|
(6)
|
(5)
|
(7)
|
(8)
|
(13)
|
(15)
|
(16)
|
(18)
|
(20)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(6)
|
(6)
|
(5)
|
(6)
|
(8)
|
(9)
|
(12)
|
(12)
|
(12)
|
(15)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(3)
|
(3)
|
(5)
|
(6)
|
(5)
|
|
| Other Operating Expenses |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(4)
-39%
|
(6)
-35%
|
(6)
-2%
|
(5)
+13%
|
(7)
-27%
|
(8)
-20%
|
(13)
-59%
|
(15)
-20%
|
(16)
-7%
|
(18)
-10%
|
(20)
-7%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(2)
|
(2)
|
(2)
|
1
|
5
|
5
|
3
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(5)
N/A
|
(6)
-28%
|
(8)
-33%
|
(5)
+35%
|
(1)
+90%
|
(2)
-351%
|
(5)
-114%
|
(14)
-163%
|
(18)
-31%
|
(19)
-9%
|
(20)
-3%
|
(21)
-3%
|
|
| Net Income | |||||||||||||
| Income from Continuing Operations |
(5)
|
(6)
|
(8)
|
(5)
|
(1)
|
(2)
|
(5)
|
(14)
|
(18)
|
(19)
|
(20)
|
(21)
|
|
| Net Income (Common) |
(5)
N/A
|
(6)
-28%
|
(8)
-33%
|
(5)
+35%
|
(1)
+90%
|
(2)
-351%
|
(5)
-114%
|
(14)
-163%
|
(18)
-31%
|
(19)
-9%
|
(20)
-3%
|
(21)
-3%
|
|
| EPS (Diluted) |
-875.8
N/A
|
-1 159.92
-32%
|
-1 492.29
-29%
|
-977.31
+35%
|
-8 916.66
-812%
|
-392.68
+96%
|
-840.65
-114%
|
-194 528.57
-23 040%
|
-254 314.28
-31%
|
-599.01
+100%
|
-145.28
+76%
|
-38.27
+74%
|
|
Switch to:
Switch to:
See Also
Discover More
